Skip to main content
TipRanks
Go Ultimate75% OFF

Top Page

JXX

Janus Henderson Transformational Growth ETF (JXX)

Rating:64Neutral
Price Target:$30.00â–²(11.94% Upside)

JXX, the Janus Henderson Transformational Growth ETF, has a solid but not top-tier rating, reflecting a mix of strong growth leaders and a few more challenged holdings. High-quality positions like TSM and Broadcom support the fund’s standing through strong financial performance and clear growth opportunities in advanced chips and AI, while Boeing’s financial difficulties and delays act as a drag. The main risk is the fund’s meaningful exposure to richly valued, growth-focused technology and semiconductor names, which could be more volatile if high expectations are not met.

Positive Factors
Strong Semiconductor and Healthcare LeadersTop holdings like TSMC, AMD, UnitedHealth, and Eli Lilly have shown strong or steady performance, helping support the ETF’s overall returns.
Focused Growth SectorsHeavy exposure to technology, health care, and consumer cyclical stocks gives investors targeted access to areas with significant long-term growth potential.
Positive Year-to-Date PerformanceDespite recent short-term weakness, the fund’s performance so far this year is positive, indicating it has held up reasonably well over a longer recent period.
Negative Factors
Mixed Results Among Top HoldingsSeveral major positions such as Oracle, Broadcom, Boeing, and Howmet Aerospace have shown weak or negative performance, which can drag on the fund’s returns.
High U.S. ConcentrationWith almost all assets in U.S. companies, the ETF offers very limited geographic diversification and is heavily tied to the U.S. market’s ups and downs.
Above-Average Expense RatioThe fund’s expense ratio is relatively high for an ETF, meaning more of investors’ returns are eaten up by fees compared with lower-cost alternatives.

JXX vs. SPDR S&P 500 ETF (SPY)

-20%-10%0%10%20%30%SPY+13.31%JXX-1.47%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AUM
21.25M
Region
North America
Expense Ratio
0.57%
Beta
1.41
Issuer
Janus Henderson
Inception Date
Feb 04, 2025
Dividend Yield
0.04%
Asset Class
Equity
Index Tracked
No Underlying Index

JXX Summary

Janus Henderson Transformational Growth ETF (JXX) is an actively managed fund that focuses on innovative large companies, mainly in technology and healthcare, rather than tracking a fixed index. It aims to find businesses driving advances in areas like artificial intelligence and medical treatments. The fund holds well-known names such as Amazon and TSMC, giving investors exposure to companies with strong growth potential in cutting-edge fields. Someone might invest in JXX to seek long-term growth and diversify into leading innovators. A key risk is that these growth-focused stocks can be more volatile and may go up and down sharply with market conditions.

How much will it cost me?

JXX has an annual expense ratio of 0.57%, which means you’ll pay about $5.70 per year for every $1,000 invested. This cost is higher than the average ETF because it’s actively managed, with professionals selecting a focused portfolio of innovative growth companies rather than simply tracking a broad market index.

What would affect this ETF?

JXX could benefit if demand for AI, cloud computing, and healthcare innovation continues to grow, supporting major holdings like TSMC, Amazon, Oracle, and UnitedHealth, and if the U.S. economy remains healthy enough to sustain spending in technology and consumer-related industries. On the downside, higher interest rates, tighter regulations on big tech or healthcare, supply chain issues affecting chipmakers and industrial names, or a slowdown in U.S. growth could hurt these companies and make this concentrated, growth-focused ETF more volatile.

JXX Top 10 Holdings

JXX is leaning hard into AI and innovation, with chip makers and cloud players setting the tone. AMD and Lumentum have been rising, giving the fund a strong tailwind from the semiconductor side, while TSM has been steadier, acting like a reliable engine rather than a rocket. On the flip side, Broadcom and Oracle have been lagging, and Amazon’s performance has been mixed, which together drag on returns. Danaher and UnitedHealth add a steadier healthcare ballast. Overall, it’s a U.S.-centric, tech-and-healthcare-heavy bet on transformational growth.

JXX top ten holdings
NameCompany NameWeight %Market ValueMarket CapYearly GainOverall Rating
TSMTSMTSMC11.66%$2.44M$1.85T31.12%81Outperform
AMZNAMZNAmazon9.20%$1.92M$2.88T9.83%71Outperform
ORCLORCLOracle7.59%$1.59M$379.03B-46.56%66Neutral
AVGOAVGOBroadcom7.06%$1.48M$1.66T-2.65%76Outperform
HWMHWMHowmet Aerospace5.42%$1.13M$87.81B4.70%67Neutral
DHRDHRDanaher5.08%$1.06M$163.94B3.93%75Outperform
AMDAMDAdvanced Micro Devices4.68%$978.93K$875.91B104.32%73Outperform
LLYLLYEli Lilly & Co4.77%$995.76K$1.36T39.64%72Outperform
UNHUNHUnitedHealth4.74%$990.94K$365.09B28.01%72Outperform
BABABoeing4.04%$843.78K$135.91B-15.06%54Neutral

JXX Technical Analysis

Technical Analysis SentimentNegative
Last Price26.80

Price Trends

50DMA30.23Negative
100DMA30.82Negative
200DMA29.53Negative

Market Momentum

MACD-0.75Negative
RSI42.78Neutral
STOCH81.55Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For JXX, the sentiment is Negative. The current price of 26.80 is below the 20-day moving average (MA) of 28.58, below the 50-day MA of 30.23, and below the 200-day MA of 29.53, indicating a bearish trend. The MACD of -0.75 indicates Negative momentum. The RSI at 42.78 is Neutral, neither overbought nor oversold. The STOCH value of 81.55 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JXX.

JXX Peer Comparison

Comparison Results

JXX against its peer funds
NamePricePrice TargetAUMExpense RatioOverall Rating
JXXJXX$26.80$30.00(11.94% Upside)$21.25M0.57%64Neutral
TMGNTMGN$23.42$30.51(30.27% Upside)$49.77M0.88%75Outperform
CCSOCCSO$23.34$31.22(33.72% Upside)$43.39M0.35%68Neutral
BUILBUIL$20.95$33.12(58.08% Upside)$41.60M0.65%70Outperform
GKGK$25.60$36.07(40.89% Upside)$29.40M0.77%71Outperform
GANZGANZ$22.72$33.05(45.48% Upside)$945.77K0.75%70Outperform

Performance Comparison

-10%0%10%20%JXXTMGNCCSOBUILGKGANZDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JXX and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JXXJanus Henderson Transformational Growth ETF26.80-0.28-1.05%
TMGNTappAlpha Cboe Magnificent 10 Growth & Daily Income ETF23.420.301.29%
CCSOCarbon Collective Climate Solutions U.S. Equity ETF23.34-0.53-2.22%
BUILRebuild America ETF20.95-3.91-15.72%
GKAdvisorShares Gerber Kawasaki ETF25.600.682.72%
GANZTuttle Capital Thematic ETF22.72-2.07-8.37%
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.